Bain Capital Life Sciences Investors Ii, Llc - Net Worth and Insider Trading

Bain Capital Life Sciences Investors Ii, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bain Capital Life Sciences Investors Ii, Llc owns 2 companies in total, including Xilio Therapeutics Inc (XLO) , and Solid Biosciences Inc (SLDB) .

Click here to see the complete history of Bain Capital Life Sciences Investors Ii, Llc’s form 4 insider trades.

Insider Ownership Summary of Bain Capital Life Sciences Investors Ii, Llc

Ticker	Comapny	Transaction Date	Type of Owner
XLO	Xilio Therapeutics Inc	2021-10-26	10 percent owner
SLDB	Solid Biosciences Inc	2022-12-02	10 percent owner

Bain Capital Life Sciences Investors Ii, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bain Capital Life Sciences Investors Ii, Llc Ownership Network

Ownership Network List of Bain Capital Life Sciences Investors Ii, Llc

No Data

Ownership Network Relation of Bain Capital Life Sciences Investors Ii, Llc

Bain Capital Life Sciences Investors Ii, Llc Owned Company Details

What does Xilio Therapeutics Inc do?

Who are the key executives at Xilio Therapeutics Inc?

Bain Capital Life Sciences Investors Ii, Llc is the 10 percent owner of Xilio Therapeutics Inc. Other key executives at Xilio Therapeutics Inc include 10 percent owner Atlas Venture Fund Xi, L.p. , Chief Medical Officer Katarina Luptakova , and Chief Operating Officer Christopher James Frankenfield .

Xilio Therapeutics Inc (XLO) Insider Trades Summary

Over the past 18 months, Bain Capital Life Sciences Investors Ii, Llc made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 485,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xilio Therapeutics Inc Insider Transactions

No Available Data

Bain Capital Life Sciences Investors Ii, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Bain Capital Life Sciences Investors Ii, Llc. You might contact Bain Capital Life Sciences Investors Ii, Llc via mailing address: 200 Clarendon Street, Boston Ma 02116.

Discussions on Bain Capital Life Sciences Investors Ii, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.